Correlation Between Biomarin Pharmaceutical and Bio Techne

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Bio Techne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Bio Techne into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Bio Techne Corp, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Bio Techne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Bio Techne. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Bio Techne.

Diversification Opportunities for Biomarin Pharmaceutical and Bio Techne

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Biomarin and Bio is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Bio Techne Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Techne Corp and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Bio Techne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Techne Corp has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Bio Techne go up and down completely randomly.

Pair Corralation between Biomarin Pharmaceutical and Bio Techne

Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Bio Techne. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 1.37 times less risky than Bio Techne. The stock trades about -0.04 of its potential returns per unit of risk. The Bio Techne Corp is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  7,523  in Bio Techne Corp on November 1, 2024 and sell it today you would lose (247.00) from holding Bio Techne Corp or give up 3.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biomarin Pharmaceutical  vs.  Bio Techne Corp

 Performance 
       Timeline  
Biomarin Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Biomarin Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Bio Techne Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Techne Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Bio Techne is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Biomarin Pharmaceutical and Bio Techne Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomarin Pharmaceutical and Bio Techne

The main advantage of trading using opposite Biomarin Pharmaceutical and Bio Techne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Bio Techne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Techne will offset losses from the drop in Bio Techne's long position.
The idea behind Biomarin Pharmaceutical and Bio Techne Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins